Table 1.47a
Percent of heart failure patients who received recommended hospital care,a Medicare beneficiaries, United States, 2002 and 2004
|
|
2004 |
2002 |
Population group |
Percent |
Standard error |
Percent |
Standard error |
Total |
77.7 |
0.2 |
73.4 |
0.2 |
Gender |
Male |
78.4 |
0.3 |
DNA |
DNA |
Female |
77.1 |
0.3 |
DNA |
DNA |
Race |
White |
77.9 |
0.3 |
73.4 |
0.3 |
Black |
78.1 |
0.6 |
74.9 |
0.7 |
Hispanic |
73.5 |
1.5 |
68.6 |
1.6 |
Native American |
72.3 |
2.3 |
68.9 |
2.3 |
Asian |
78.6 |
2.1 |
76.3 |
2.3 |
Age |
Under 65 |
76.0 |
0.7 |
DNA |
DNA |
65-74 |
80.0 |
0.4 |
DNA |
DNA |
75-84 |
78.3 |
0.4 |
DNA |
DNA |
85 and over |
75.3 |
0.5 |
DNA |
DNA |
a Recommended hospital care for heart failure includes receiving evaluation of left ventricular ejection fraction, and prescription of an angiotensin converting enzyme (ACE) inhibitor at discharge for patients with left ventricular systolic dysfunction.
DNA - Data have not been analyzed.
Source: Centers for Medicare & Medicaid Services, Medicare Quality Improvement Organization Program.
Return to Contents